These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 28606919)
1. Expression and Therapeutic Potential of SOX9 in Chordoma. Chen H; Garbutt CC; Spentzos D; Choy E; Hornicek FJ; Duan Z Clin Cancer Res; 2017 Sep; 23(17):5176-5186. PubMed ID: 28606919 [No Abstract] [Full Text] [Related]
2. Expression of Reg IV and SOX9 and their correlation in human gastric cancer. Zhang N; Chai D; Du H; Li K; Xie W; Li X; Yang R; Lian X; Xu Y BMC Cancer; 2018 Mar; 18(1):344. PubMed ID: 29587675 [TBL] [Abstract][Full Text] [Related]
3. Decreased expression of SOX9 indicates a better prognosis and inhibits the growth of glioma cells by inducing cell cycle arrest. Gao J; Zhang JY; Li YH; Ren F Int J Clin Exp Pathol; 2015; 8(9):10130-8. PubMed ID: 26617720 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9. Liu N; Zhang L; Wang Z; Cheng Y; Zhang P; Wang X; Wen W; Yang H; Liu H; Jin W; Zhang Y; Tu Y Oncotarget; 2017 Mar; 8(12):19244-19254. PubMed ID: 27911279 [TBL] [Abstract][Full Text] [Related]
5. Sex Determining Region Y Box 9 Induces Chemoresistance in Pancreatic Cancer Cells by Induction of Putative Cancer Stem Cell Characteristics and Its High Expression Predicts Poor Prognosis. Higashihara T; Yoshitomi H; Nakata Y; Kagawa S; Takano S; Shimizu H; Kato A; Furukawa K; Ohtsuka M; Miyazaki M Pancreas; 2017; 46(10):1296-1304. PubMed ID: 28984791 [TBL] [Abstract][Full Text] [Related]
6. Association between SOX9 and CA9 in glioma, and its effects on chemosensitivity to TMZ. Xu X; Wang Z; Liu N; Cheng Y; Jin W; Zhang P; Wang X; Yang H; Liu H; Zhang Y; Tu Y Int J Oncol; 2018 Jul; 53(1):189-202. PubMed ID: 29749469 [TBL] [Abstract][Full Text] [Related]
7. EP300 through upregulating the expression of vimentin to promote the progression of chordoma. Wen L; Xie B; Li H; Huang J; Shi Y; Tao Y; Chen Y Neurosurg Focus; 2024 May; 56(5):E17. PubMed ID: 38691868 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of sex-determining region Y-box 9 (SOX9) promotes cell proliferation and tumorigenicity in esophageal squamous cell carcinoma. Hong Y; Chen W; Du X; Ning H; Chen H; Shi R; Lin S; Xu R; Zhu J; Wu S; Zhou H Oncotarget; 2015 Oct; 6(31):31241-54. PubMed ID: 26384302 [TBL] [Abstract][Full Text] [Related]
10. A novel target for treatment of chordoma: signal transducers and activators of transcription 3. Yang C; Schwab JH; Schoenfeld AJ; Hornicek FJ; Wood KB; Nielsen GP; Choy E; Mankin H; Duan Z Mol Cancer Ther; 2009 Sep; 8(9):2597-605. PubMed ID: 19723879 [TBL] [Abstract][Full Text] [Related]
11. Characterization of cancer stem-like cells in chordoma. Aydemir E; Bayrak OF; Sahin F; Atalay B; Kose GT; Ozen M; Sevli S; Dalan AB; Yalvac ME; Dogruluk T; Türe U J Neurosurg; 2012 Apr; 116(4):810-20. PubMed ID: 22283189 [TBL] [Abstract][Full Text] [Related]
13. CDK4 expression in chordoma: A potential therapeutic target. Liu T; Shen JK; Choy E; Zhang Y; Mankin HJ; Hornicek FJ; Duan Z J Orthop Res; 2018 Jun; 36(6):1581-1589. PubMed ID: 29194728 [TBL] [Abstract][Full Text] [Related]
14. Blockage of Stat3 with CDDO-Me inhibits tumor cell growth in chordoma. Yang C; Hornicek FJ; Wood KB; Schwab JH; Choy E; Mankin H; Duan Z Spine (Phila Pa 1976); 2010 Aug; 35(18):1668-75. PubMed ID: 20386502 [TBL] [Abstract][Full Text] [Related]
15. The effects of lncRNA MALAT1 on proliferation, invasion and migration in colorectal cancer through regulating SOX9. Xu Y; Zhang X; Hu X; Zhou W; Zhang P; Zhang J; Yang S; Liu Y Mol Med; 2018 Oct; 24(1):52. PubMed ID: 30285605 [TBL] [Abstract][Full Text] [Related]
16. Role of LASP-1, a novel SOX9 transcriptional target, in the progression of lung cancer. Shi J; Guo J; Li X Int J Oncol; 2018 Jan; 52(1):179-188. PubMed ID: 29138807 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-494 inhibits cell proliferation and invasion of chondrosarcoma cells in vivo and in vitro by directly targeting SOX9. Li J; Wang L; Liu Z; Zu C; Xing F; Yang P; Yang Y; Dang X; Wang K Oncotarget; 2015 Sep; 6(28):26216-29. PubMed ID: 26317788 [TBL] [Abstract][Full Text] [Related]
18. Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9. Wang J; Xue X; Hong H; Qin M; Zhou J; Sun Q; Liang H; Gao L Oncotarget; 2017 Jan; 8(1):574-582. PubMed ID: 27880941 [TBL] [Abstract][Full Text] [Related]
19. T-LAK cell-originated protein kinase (TOPK) is a Novel Prognostic and Therapeutic Target in Chordoma. Thanindratarn P; Dean DC; Nelson SD; Hornicek FJ; Duan Z Cell Prolif; 2020 Oct; 53(10):e12901. PubMed ID: 32960500 [TBL] [Abstract][Full Text] [Related]
20. SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types. Richtig G; Aigelsreiter A; Schwarzenbacher D; Ress AL; Adiprasito JB; Stiegelbauer V; Hoefler G; Schauer S; Kiesslich T; Kornprat P; Winder T; Eisner F; Gerger A; Stoeger H; Stauber R; Lackner C; Pichler M PLoS One; 2017; 12(11):e0187814. PubMed ID: 29121666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]